A new 2020 feature on the fast moving medical cannabis market in Denmark
Invest in Denmark is featured in The Open Access Government January 2020 publication wherein our Special Advisor, Derek Light and Investment Manager, Michael Prytz talk about the rapid development in the medical cannabis market in Denmark and Europe.
A rapid development in Denmark
Denmark offers a solid and reliable entry-point into the European medical cannabis market. In January 2018, the Danish government implemented a four-year medical cannabis pilot programme along with a special development scheme that provides licenses to grow and handle cannabis to develop medical cannabis based products. In November 2018, the government passed a subsequent motion to allow bulk exports of medical cannabis.
The medical cannabis market has developed rapidly since 2018. The dominos are falling and several countries across Europe and the world are adopting medical cannabis programs. Denmark is on track to be one of the world’s largest GACP cultivation nations with more than 3 million SQF of cultivation on its way to be built out. The Open Access Government January 2020 publication has just landed wherein our Special Advisor, Derek Light and Investment Manager, Michael Prytz talk about the medical cannabis market in Denmark and Europe.
Read the full article hereSeveral of the largest companies in the industry have already set up in Denmark, based on strong but transparent regulations, availability of expertise and experience from both the pharma and horticulture sectors, strong commitment to innovation, sustainability, and cutting edge automated production methods, and opportunities for growth in the Danish and European markets.
Medical Cannabis
facts Top reason for choosing Denmark for medical cannabis activities
- Attractive framework conditions with strong government support for medical cannabis and a transparent regulatory regime.
- Access to expertise in pharma production including availability of expertise in developing GMP compliant facilities and processes.
- Proximity to main EU markets including Germany with excellent infrastructure for exports, transport and shipping.
- Strong plant genetics and breeding ecosystem.
- A well-funded healthcare system offering partial reimbursement for medical cannabis based products and an efficient retail pharmacy network for product distribution.
- No medical cannabis production cap or quotas.
- Availability of land and high degree of agricultural automation.
- Access to reliable green power at a low cost.
- Skilled horticulture and manufacturing labour force, with training modules available to reinforce skills specific to the production of medical cannabis.
Contact Get in touch
Want to know more about the medical cannabis industry and opportunities in Denmark? Fill out the form and we will get back to within 48 hours.Want to contact us straight away?
Please get in touch if you want to know more about the medical cannabis market in Denmark.